Monday, July 23, 2018

Orthobiologics Market Gain Impetus due to the Growing Demand over 2023


The global orthobiologics market is driven by increasing sports injuries and road accidents, increased obesity rate, growing awareness among people, and surging aging population. Moreover, the opportunities witnessed in the global market include development in implant technologies and shifting demand from mechanical to biological solutions. The global market has been classified in terms of product, application, end-user and geography. Based on product, the global market is segmented into bone morphogenetic proteins, demineralized bone matrix, synthetic bone substitute, allograft, viscosupplementation, machined bones, and stem cell therapy. Based on end user, the global market is segmented into orthopedic clinics, hospitals, and others.


Orthobiologics are substances used by orthopedic surgeons for facilitating quick healing of injuries of broken bones and injured muscles, ligaments, and tendons. These products are usually made from substances found naturally in the human body. The reasons for the increasing popularity of these products include faster healing and recovery, and less need for frequent hospital visits.


Global Orthobiologics Market Segmentation

By Product
·         Bone Morphogenetic Proteins
·         Demineralized Bone Matrix
·         Synthetic Bone Substitute
·         Allograft,
·         Viscosupplementation,
·         Machined Bones
·         Stem Cell Therapy
By Application
·         Reconstructive Surgery
·         Spinal Fusion
·         Trauma
By End User
·         Orthopedic Clinics
·         Hospitals
·         Others
By Geography
·         North America
·         Europe
·         Asia
·         Rest of the World (RoW)

The geographical segmentation of the global orthobiologics market includes North America, Europe, Asia-Pacific and Rest of the World (RoW). North America and Europe accounted for major share in the global market, since the regions have the highest aging population, due to increase in life expectancy and prevalence of geriatric-based diseases, such as diabetes, arthritis, and obesity. The Asia-Pacific market is expected to witness surge, due to the enormous untapped patient population, increasing medical tourism, and economical treatment cost. The developing nations, such as India and China, in the Asia-Pacific market are expected to witness significant growth.

The major companies operating in the global orthobiologics market include Exactech Inc., Medtronic plc., Stryker Corporation, Synthes Inc., Smith & Nephew Plc, Zimmer Biomet, DePuy Synthes Inc (Johnson & Johnson), Tornier Inc., and others.

About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Connect with us: LinkedIn | Twitter | Google + | Facebook

No comments:

Post a Comment